Sana Biotechnology Inc (SANA) concluded trading on Thursday at a closing price of $5.71, with 2.23 million shares of worth about $12.72 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -29.42% during that period and on August 22, 2024 the price saw a gain of about 7.74%. Currently the company’s common shares owned by public are about 197.86M shares, out of which, 120.93M shares are available for trading.
Stock saw a price change of 14.43% in past 5 days and over the past one month there was a price change of -6.70%. Year-to-date (YTD), SANA shares are showing a performance of 39.95% which increased to 1.96% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.74 but also hit the highest price of $12.00 during that period. The average intraday trading volume for Sana Biotechnology Inc shares is 1.78 million. The stock is currently trading 8.84% above its 20-day simple moving average (SMA20), while that difference is up 2.17% for SMA50 and it goes to -13.24% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sana Biotechnology Inc (NASDAQ: SANA) currently have 197.86M outstanding shares and institutions hold larger chunk of about 51.05% of that.
The stock has a current market capitalization of $1.27B and its 3Y-monthly beta is at 1.44. It has posted earnings per share of -$1.15 in the same period. It has Quick Ratio of 5.20 while making debt-to-equity ratio of 0.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SANA, volatility over the week remained 5.75% while standing at 8.07% over the month.
Stock’s fiscal year EPS is expected to rise by 17.60% while it is estimated to increase by 3.17% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Rodman & Renshaw on June 26, 2024 offering a Buy rating for the stock and assigned a target price of $16 to it. Coverage by H.C. Wainwright stated Sana Biotechnology Inc (SANA) stock as a Buy in their note to investors on January 16, 2024, suggesting a price target of $12 for the stock. On September 25, 2023, JMP Securities Initiated their recommendations, while on September 05, 2023, Citigroup Initiated their ratings for the stock with a price target of $8. Stock get a Market perform rating from TD Cowen on August 14, 2023.
